merged_eu-covid-vaccines.txt
<question_number>1</question_number>  
<answer>The court ruling casts a shadow on Ursula von der Leyen's leadership, potentially impacting her chances of securing a second term by fueling criticism and distrust, especially as she needs a broad coalition to secure the necessary votes.</answer>  

<question_number>2</question_number>  
<answer>The article implies that the lack of transparency in the vaccine contracts under Ursula von der Leyen's leadership has contributed to a sense of distrust among European voters, which has coincided with the rise of far-right politicians in the European Parliament.</answer>  

<question_number>3</question_number>  
<answer>The article suggests that Ursula von der Leyen's handling of the vaccine contracts has strained her political alliances, particularly with the Greens, who are incensed by her handling of the coronavirus crisis and are critical of her secrecy.</answer>  

<question_number>4</question_number>  
<answer>The article implies that the European Commission's vaccine procurement strategy, marked by secrecy and lack of transparency, has contributed to a sense of distrust among voters, which has coincided with the rise of far-right politicians in the European Parliament.</answer>  

<question_number>5</question_number>  
<answer>The court's ruling highlights the lack of transparency in the vaccine contracts, which has fueled criticism and distrust among voters, contributing to the political environment that has seen a rise in far-right politicians in the European Parliament.</answer>  

<question_number>6</question_number>  
<answer>The timing of the court's ruling, just ahead of the vote on von der Leyen's future, adds pressure and casts doubt on her leadership, potentially influencing the outcome of the vote.</answer>  

<question_number>7</question_number>  
<answer>The paradoxical shift in the EU's vaccine procurement strategy under von der Leyen's leadership was from a slow start to later catching up and surpassing other countries after securing a contract with Pfizer-BioNTech.</answer>  

<question_number>8</question_number>  
<answer>The European Commission's statement on the court ruling contradicts its past actions by claiming it provided full information to the European Parliament, despite the court finding that it wrongly withheld information and redacted parts of the purchasing agreements.</answer>  

<question_number>9</question_number>  
<answer>The court's ruling reinforces the importance of freedom of information, which aligns with The New York Times' pending legal case seeking access to text messages between von der Leyen and Pfizer's CEO.</answer>  

<question_number>10</question_number>  
<answer>The court's ruling may negatively affect public perception of the EU's pandemic response by highlighting the lack of transparency and secrecy in vaccine contracts, especially amid recent political shifts and the rise of far-right politicians.</answer>